Joom!Fish config error: Default language is inactive!
 
Please check configuration, try to use first active language

Case A4: Positive DAT in a Recently Transfused Nonagenarian
 

TraQ Program of the BC PBCO

Home Case Studies A-Level Case A4: Positive DAT in a Recently Transfused Nonagenarian
Friday, 22 September 2017

Case A4: Positive DAT in a Recently Transfused Nonagenarian

We welcome feedback: Contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Last Updated: Oct. 12, 2016 [All links updated]

If you find errors or have suggestions, fire away!

Contributed by: Darlene Mueller, ART, Matsqui - Abbotsford - Sumas (MSA) General Hospital

HISTORY

Mrs. A.L., a 91-year-old female, was admitted for left hip surgery on April 2. Her hemoglobin was 92g/L and two units of RBC were ordered for her surgery

  • Pregnancies: 3 prior pregnancies
  • Transfusion: 2 units of RBC 9 years ago with no adverse reactions

APRIL 2

Based on these results, Mrs. AL was transfused with two units of RBC on April 2. No adverse reaction was reported.

JUNE 22

Twelve weeks later, Mrs. AL was admitted to hospital for complication of the left hip. Two units of RBC were ordered for her surgery.

The transfusion service technologist notified the attending physician and surgeon that the patient?s antibody screen was positive and compatible blood would be delayed. The post-transfusion specimen showed no visible hemolysis or icterus.

CASE SUMMARY AND QUIZ

After reviewing the case summary, consider these questions.

With regard to delayed hemolytic transfusion reactions (DHTR):

  1. Which antibodies are commonly involved?

    Answer

  2. How long following transfusion do they usually occur?

    Answer

  3. What are the main symptoms?

    Answer

  4. What is the prognosis and treatment?

    Answer

  5. Which non-serological laboratory test results may be helpful when investigating DHTR?

    Answer

  6. How are such reactions usually discovered and how do they present in the transfusion service?

    Answer

Further Reading

Pineda AA, Vamvakas EC, Gorden LD, Winters JL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999 Oct;39(10):1097-103. [ Medline ]

Schonewille, H., Haak, H.L., van Zijl, A.M. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999 Jul;39(7):763-71. [ Medline ]

Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000 Sep;40(9):1127-31. [ Medline ]

Vamvakas EC, Pineda AA, Reisner R, Santrach PJ, Moore SB. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995 Jan;35(1):26-32. [ Medline ]